https://www.marketprism.co/blog/2026-10-02-immunitybio-ibrx-when-narrative-velocity-outpaces-fundamental-anchors Market Prism en 2026-10-02T17:06:23.899Z ImmunityBio (IBRX): When Narrative Velocity Outpaces Fundamental Anchors IBRX, Market Intel, market analysis, narrative intelligence https://www.marketprism.co/og-image/2026-10-02-immunitybio-ibrx-when-narrative-velocity-outpaces-fundamental-anchors ImmunityBio (IBRX): When Narrative Velocity Outpaces Fundamental Anchors https://www.marketprism.co/blog/2026-10-01-vale-q1-earnings-forensic Market Prism en 2026-10-01T16:47:44.487Z VALE Q1 2026: A Flat Headline Print That Obscures a Structurally Complicated Underlying Picture VALE, Post-Earnings, market analysis, narrative intelligence https://www.marketprism.co/og-image/2026-10-01-vale-q1-earnings-forensic VALE Q1 2026: A Flat Headline Print That Obscures a Structurally Complicated Underlying Picture